Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07502209

Notch vs Midpoint Suprascapular Nerve PRF for Chronic Shoulder Pain

Conditions: Chronic Shoulder Pain, Rotator Cuff Tendinopathy

Sex: All
Ages: 40 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 32
Sponsor: Ankara City Hospital Bilkent

Location: Ankara Bilkent City Hospital Ankara

Summary

This study aims to compare the effects of pulsed radiofrequency (PRF) treatment of the suprascapular nerve using suprascapular notch and midpoint approaches on pain, shoulder function, and muscle strength in patients with chronic shoulder pain due to rotator cuff tendinopathy. Patients will be randomly assigned to one of the two intervention groups. Clinical evaluations will include pain assessment using the Numeric Rating Scale (NRS), functional assessment using the Shoulder Pain and Disability Index (SPADI), and quality of life assessment using the Short Form-36 (SF-36). In addition, shoulder range of motion will be measured goniometrically, muscle thickness of the supraspinatus and infraspinatus will be evaluated by ultrasonography, and shoulder muscle strength will be assessed using an isokinetic dynamometer. Assessments will be performed at baseline, 24 hours, 1 month, and 3 months after the intervention. The results of this study are expected to provide evidence regarding the optimal approach for PRF treatment of the suprascapular nerve in patients with chronic shoulder pain.

Eligibility Criteria

Inclusion Criteria: * Patients aged between 40 and 80 years * Patients with chronic shoulder pain lasting longer than 3 months * Patients diagnosed with rotator cuff-related shoulder pain * Patients who show at least 50% pain reduction after diagnostic suprascapular nerve block * Patients who provide written informed consent Exclusion Criteria: * Adhesive capsulitis * Previous shoulder surgery * Full-thickness rotator cuff tear * Neurological disorders affecting the shoulder * Pacemaker * Coagulopathy or anticoagulant therapy contraindicating intervention * Infection at the injection site * Severe systemic disease * Pregnancy * Inability to comply with study protocol

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07502209). StuddyBuddy aggregates publicly available trial information.